Trial Details
TERMINATEDBasic Information
| Clinical ID | c1271 |
|---|---|
| Identifier | NCT00488774 |
| Trial Title | An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | OTHER: Placebo|DRUG: Golimumab 1 mg per kg|DRUG: Golimumab 2 mg per kg|DRUG: Golimumab 4 mg per kg |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Orange |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2025-08-07 |
|---|---|
| Primary Completion Date | 2025-05-09 |
| Completion Date | 2025-05-09 |